Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$285K Sell
2,780
-43
-2% -$4.86K 0.03% 183
2025
Q4
$354K Buy
2,823
+268
+10% +$34.1K 0.03% 161
2025
Q3
$342K Sell
2,555
-32
-1% -$4.2K 0.03% 152
2025
Q2
$352K Sell
2,587
-433
-14% -$57.1K 0.04% 145
2025
Q1
$401K Sell
3,020
-288
-9% -$36.7K 0.05% 141
2024
Q4
$374K Buy
3,308
+660
+25% +$76.3K 0.05% 139
2024
Q3
$301K Sell
2,648
-28
-1% -$3.07K 0.04% 141
2024
Q2
$278K Buy
2,676
+4
+0.1% +$424 0.04% 139
2024
Q1
$304K Sell
2,672
-127
-5% -$14.6K 0.04% 143
2023
Q4
$308K Sell
2,799
-250
-8% -$25K 0.05% 139
2023
Q3
$295K Sell
3,049
-56
-2% -$5.88K 0.05% 135
2023
Q2
$338K Buy
+3,105
New +$331K 0.06% 132

Other funds holding ABT

Nemes Rush Group's ABT Position: Q1 2026 in Review

Nemes Rush Group reduced its Abbott (ABT) stake by 1.5% in Q1 2026, selling an estimated $4.86K and leaving 2,780 shares worth $285K. The position accounts for 0.03% of the portfolio, ranked #183.

Nemes Rush Group first reported a position in ABT in Q2 2023 and has held it in 12 quarters since. The position peaked at $401K in Q1 2025. 3,089 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Nemes Rush Group held 2,780 shares of Abbott worth $285K as of Q1 2026.
  • Nemes Rush Group sold 43 Abbott shares in Q1 2026, an estimated $4.86K.
  • Abbott made up 0.03% of Nemes Rush Group's portfolio in Q1 2026, its #183 holding.
  • Nemes Rush Group first reported a position in Abbott in Q2 2023 and has held it in 12 quarters since.
  • Nemes Rush Group's Abbott position peaked at $401K in Q1 2025.
  • 3,089 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.